TAC was invited to give a talk on novel antibody production at the most recent ELRIG conference. Dr Jack Bryson presented “Production of Monoclonal Antibodies using a Phage-Display scFv Library: a Faster, More Flexible, and More Secure Complement to Hybridoma”.

This generated a lot of discussion with some very interesting proposals for projects utilising this technology and leveraging its advantages.

As an added bonus it was fantastic to see the BICR again. It has been many years since I have been there. It is a wonderful state of the art facility run by extremely dedicated scientists.

By J S Beesley – Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=50118277
Posted in

Why use us?

  • Rapid and competitive quotation
  • Flexible project start and end points
  • Experienced team and project management
  • Real-time project updates and technical support
  • No customs delays, no duty and overseas shipping for UK based companies
  • Same day shipping
  • Specialist problem solvers

Virtual Lab for early stage companies

De-risk promising early stage technology by using The Antibody Company's integrated research and production facilities and over 20 years' experience for developing diagnostics and therapeutics. Our Virtual Lab packages can speed up the process and save significant up-front expenditure on specialist equipment and staff.

We offer our Virtual Lab expertise for assistance and partnering in grant and commercial applications.


Talk to us about a service

The Antibody Company offers competitive pricing for single phase or the entire process of generating high-quality monoclonal antibodies and assays.

Scroll to Top